Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 3.07
-0.325 %
$ 280 M
Market Cap
-6.82
P/E
AQST - COST OF REVENUE
Cost of Revenue AQST - Aquestive Therapeutics, Inc.
20.8 M
LAST VALUE
17.89%
2 YEAR CAGR
-0.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR